AnthonyMMaglioccoMDFRCPC FCAP

PubMed

• Validation of PRKCB Immunohistochemistry as a Biomarker for the Diagnosis of Ewing Sarcoma.
  Victor Zota, Gene P Siegal, David Kelly, Julia A Bridge, Anders Berglund
  Fetal and Pediatric Pathology. 2023-04-01
• Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy.
  Anthony M Magliocco, Jennifer Moughan, David T Miyamoto, Jeff Simko, William U Shipley
  JAMA Network Open. 2022-11-01
• 2 citations
  Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clin...
  Daryoush Saeed-Vafa, Douglas C. Marchion, Susan M McCarthy, Ardeshir Hakam, Alexis S. Lopez
  Plos One. 2021-11-23

Journal Articles

• Identification of Nine New Susceptibility Loci for Endometrial Cancer  
  Gloria E Sarto, Stephen J Chanock, Anthony M Magliocco, Nature
• Utility of digital image analysis in the identification of tall call variant of papillary thyroid carcinoma (TCV-PTC): Are we ready for the next step?  
  Hernandez-Prera, J.C., Urken, M.L., Xiong, Y., Johnson, J., Kasprzak, A., Bui, M., Magliocco, A. and Wenig, B., Modern Pathology, 1/1/2018
• Female Chromosome X Mosaicism Is Age-Related and Preferentially Affects the Inactivated X Chromosome  
  Chu Chen, J Michael Gaziano, Robert C Kurtz, Anthony M Magliocco, Amy Hutchinson, Robert R McWilliams, Nature
• Digital differentiation of non-small cell carcinomas of the lung by the fractal dimension of their epithelial architecture  
  Lee LH, Tambasco M, Otsuka S, Wright A, Klimowicz A, Petrillo S, Morris D, Magliocco A, Bebb DG, Micron, 1/1/2014
• The Significance of Tumoral ERCC1 Status in Patients With Locally Advanced Cervical Cancer Treated With Chemoradiation Therapy: A Multicenter Clinicopathologic Analysis.  
  Doll CM, Aquino-Parsons C, Pintilie M, Klimowicz AC, Petrillo SK, Milosevic M, Craighead PS, Clarke B, Lees-Miller SP, Fyles AW, Magliocco AM, Int J Radiat Oncol Biol Phys, 7/24/2012
• Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53.  
  Williamson CT, Kubota E, Hamill JD, Klimowicz A, Ye R, Muzik H, Dean M, Tu L, Gilley D, Magliocco AM, McKay BC, Bebb DG, Lees-Miller SP, EMBO Mol Med, 3/1/2012
• Erratum to: Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment.  
  Pohorelic B, Singh R, Parkin S, Koro K, Yang AD, Egan C, Magliocco A, Breast Cancer Res Treat, 10/11/2011
• Analysis of multiple growth regulatory proteins using dissociable staining antibody arrays on solid tumor biopsy specimens.  
  Blackmore C, Jayanthan A, Ujack E, Magliocco T, Narendran A, Fetal Pediatr Pathol, 1/1/2011
• Susceptibility of mantle cell lymphomas to reovirus oncolysis.  
  Alain T, Muzik H, Otsuka S, Chan S, Magliocco T, Diaz R, Forsyth PA, Morris D, Bebb G, Leuk Res, 1/1/2010
• Best practice recommendations for standardization of immunohistochemistry tests.  
  Torlakovic Emina Emilia, Riddel Robert, Hewlett Bryan, Banerjee Diponkar, et al, Canadian Journal of Pathology, 7/1/2009
• Methylation status of MGMT gene promoter in meningiomas.  
  de Robles P, McIntyre J, Kalra S, Roldan G, Cairncross G, Forsyth P, Magliocco T, Hamilton M, Easaw J, Cancer Genet Cytogenet, 11/1/2008
• Heterotopic ossification in rectal cancer.  
  Magliocco AM, J Surg Oncol, 2/1/2003
• Commentary (on Phase III comparison of docetaxel (D) and paclitaxel (P) in patients with metastatic breast cancer (MBC): Notable reports from Nottingham and ECCO).  
  Magliocco AM, Innovations in Breast Cancer Care, 1/1/2003
• What does HER2 tell us in the adjuvant setting.  
  Magliocco AM, Oncology Exchange, 1/1/2003
• Commentary on Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.  
  Magliocco A, J Surg Oncol, 1/1/2002
• Update on Advanced Diagnostics  
  Magliocco AM, Banerjee, CAP newsletter, 1/1/2002
• Varicella embryopathy.  
  Magliocco AM, Demetrick DJ, Sarnat HB, Hwang WS, Arch Pathol Lab Med, 2/1/1992
• Decidualized endometriosis causing inversion of the appendix, massive hemorrhage and fetal death.  
  Magliocco A, Kelly J, Mulloy B, Preshaw W, Can J Gastroenterol, 1/1/1991
• Join now to see all

Abstracts/Posters

• HPV Genotyping of Penile Carcinomas by Real-Time Polymerase Chain Reaction (qPCR) and Multi-color Melting Curve Analysis (MMCA) of formalin fixed paraffin embedded (FF...
  Gadara M., Kothapalli R., Magliocco G., Spiess PE., Magliocco AM., Dhillon J., USCAP Annual Meeting, Vancouver, British Cloumbia, Canada, 1/17/2018
• Analysis of Gene Expression and Mutations Involved in Epigenetic Regulation of Endometrial Carcinoma
  Gadara, M., Toruner, G., Teer, J.K., Xiong, Y., Welsh, E.A., Zhang, Y.O., Magliocco, A. and Saglam, O., Modern Pathology, 1/1/2018
• Leveraging Digital Pathology to Identify Biomarkers in Ewing Sarcoma
  Saeed-Vafa, D., Brohl, A.S., Xiong, Y., Magliocco, A. and Bui, M., Modern Pathology, 1/1/2018
• Improving the sensitivity of wide targeted cancer gene panels via novel genome analysis tools
  Kermani, BG., Roberts, EL., Boyle, TA., Magliocco, AM, American Association for Cancer Research, 1/1/2018
• Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525
  Bell EH, Pugh SL, McElroy JP, Gilbert MR, Mehta M, Klimowicz AC, Magliocco AM, Bredel M, Robe P, Grosu AL, Stupp R, JAMA Oncol, 1/12/2017
• Cmet-36. Detection, Molecular Profiling And Culture Of Csf-ctcs In Leptomeningeal Disease (lmdz) In Melanoma
  Evernden B, Law V, Kenchappa R, Puskas J, Ryzhova E, Fedorenko I, Tran ND, Etame AB, Sahebjam S, Magliocco A, Smalley K, Neuro-oncology, 1/6/2017
• Expression of PD-L1 and presence of CD8-positive T cells in pre-treatment specimens of locally advanced cervical cancer
  Enwere EK, Kornaga EN, Dean M, Koulis TA, Phan T, Kalantarian M, K�bel M, Ghatage P, Magliocco AM, Lees-Miller SP, Doll CM, Modern Pathology, 1/6/2017
• Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRAIL
  D Yee, A De Michele, C Isaacs, F Symmans, C Yau, KS Albain, NM Hylton, A Forero-Torres, LJ van't Veer, J Perlmutter, HS Rugo, M Melisko, Y-Y Chen, R Balassanian, G Kri..., San Antonio Breast Cancer Symposium, 1/5/2017
• Targeted inhibition of the (BAD) apoptotic signaling pathway increases the chemo-sensitivity of triple negative breast cancer cells
  Boac BM, Abbasi F, Han M, Ismail-Khan R, Xiong Y, Lopez A, Ayral TJ, Todd SL, Berglund AE, Magliocco AM, and Marchion DC, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• Evaluation of a novel in-vitro 4D tumoroid cellular culture system for creating models of chemoresistance in progressive ovarian cancer and malignant ascites
  Han M, Marchion DC, Todd SL, Boac BM, Xiong Y, Ayral TJ, Wenham RM, Mohapatra S, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• The molecular profiles of ascites-derived ovarian cancer cells are different than the primary tumor
  Marchion DC, Robertson SE, Boac BM, Xiong Y, Todd SL, Yao J, McClung EC, Saeed-Vafa D, Wenham RM, Welsh EA, Berglund AE, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• Characterization of the immune microenvironment in matching samples of primary ovarian tumors and malignant ascites
  Todd SL, Robertson SE, Saeed-Vafa D, Berglund AE, Han M, Boac BM, McClung EC, Ayral TJ, Xiong Y, Wenham RM, Marchion DC, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• Epithelial ovarian cancer sensitivity to cisplatin is enhanced by class I histone deacetylase inhibitor MS275 via chromatin decondensation
  Todd SL, George T, Henry B, Han M, Boac BM, Ayral TJ, Xiong Y, Wenham RM, Marchion DC, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• Oncogenic viral DNA in ovarian cancer: a marker of decreased immune reactivity and survival probability
  Robertson SE, Marchion DC, Saeed-Vafa D, Todd SL, Berglund AE, Wenham RM, Tomassino M, Giuliano AR, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• HSP90 inhibition enhances carboplatin sensitivity via AKT inactivation
  Boac BM, Abbasi F, Marchion DC, Xiong Y, Han M, Ayral TJ, Todd SL, Robertson SE, McClung EC, and Magliocco AM, 3rd Annual Moffitt Pathology and Histotechnology Symposium, Sarasota, FL, 1/3/2017
• Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology...
  Lawrence, Y. R., Moughan, J., Magliocco, A. M., Klimowicz, A. C., Regine, W. F., Mowat, R. B., DiPetrillo, T. A., Small, W., Simko, J. P., Golan, T., Winter, K. A., Gu..., Cancer, 1/1/2017
• Gene expression analysis identifies immunological MRNA up regulation in cells in the ascites of serous ovarian cancer as compared to matched primary tumor
  Robertson SE, Marchion DC, Xiong Yi, Berglund AE, Magliocco AM, Clin Cancer Res, 1/1/2017
• Histone deacetylase inhibitor MS-275 potentiates cisplatin toxicity in epithelial ovarian cancer
  S.L. Todd, T. George, B. Henry, M. Han, B.M. Boac, T. Ayral, Y. Xiong, D.C. Marchion, A. Magliocco, R.M. Wenham, Gynecologic Oncology, 1/1/2017
• Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC
  Petersen LF, Klimowicz AC, Otsuka S, Magliocco AM, et al, Oncotarget, 1/1/2017
• Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis...
  Doll CM, Moughan J, Klimowicz A, Ho CK, Kornaga EN, Lees-Miller SP, Ajani JA, Crane CH, Kachnic LA, Okawara GS, Berk LB, Roof KS, Becker MJ, Grisell DL, Ellis RJ, Sper..., International Journal of Radiation Oncology Biology Physics, 1/1/2017
• Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study
  Koulis TA, Kornaga EN, Banerjee R, Phan T, Ghatage P, Magliocco AM, Lees-Miller SP, Doll CM, Clinical and Translational Radiation Oncology, 1/1/2017
• Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas
  Permuth JB, Chen DT, Yoder SJ, Li J, Smith AT, Choi JW, Kim JP, Balagurunathan Y, Jiang K, Coppola D, Centeno BA, Klapman J, Hodul P, Karreth FA, Trevino JG, Merchant ..., Scientific Reports, 1/1/2017
• Refining the prognostic value of Ki67 biomarker by ataxia telangiectasia mutated (ATM) status in a retrospective study of early stage hormone receptor positive breast ...
  Feng X, Li H, Kornarga E, Dean M, Lees-Miller S, Riabowol K, Magliocco AM, Morris D, Watson P, Enwere E, Bebb G, Paterson A, Cancer Research, 1/1/2017
• Clinical utility of PgR with various cutpoints using 3 commercial assays relative to 15yr survival
  Kornaga EN, Paterson AHG, Feng X, Morris DG, Magliocco AM, Klimowicz AC, Cancer Research, 1/1/2017
• Correlation of breast cancer index (BCI) risk classification with tumor grade and Ki-67 in a large series of patients with early-stage, ER plus breast cancer
  Soliman H, Schroeder BE, Zhang Y, Magliocco AM, Schnabel CA, Cancer Research, 1/1/2017
• Join now to see all

Lectures

• Bringing Digital Pathology to the CLIA Laboratory: The Moffitt Experience 
  Vancouver, British Columbia, Canada - 1/17/2018
• Implementing Personalized oncology and impacts on pathology: The Moffitt Cancer Center Experience 
  St. Augustine, FL - 1/28/2017
• Emerging Data on Bladder Preservation 
  San Diego, CA - 1/27/2017
• Reaching the Summit 
  Salt Lake City, UT - 1/15/2017
• Latest Advances in Precision Oncology 
  Salt Lake City, UT - 1/15/2017
• What in the world Is viral DNA doing in Triple Negative Breast Cancer 
  GRIPS � Moffitt Cancer Center, Tampa, FL - 1/7/2017
• Challenges and opportunities for digital PCR in the Cancer CLIA laboratory: the Moffitt Cancer Center Experience 
  Europe, London, United Kingdom - 1/5/2017
• Moffitt Cancer Center Working Across Disciplines to Deliver the Optimal Patient Outcome 
  Charleston, SC - 1/30/2016
• Welcome Address, Practicing Pathology in a Changing World 
  1/26/2016
• Opportunities and challenges of bringing digital pathology to the clinic 
  1/26/2016
• Joint Pathology-Radiology Workshop: Best Practices for Lung and Liver Tumor Biopsies 
  Bethesda, MD - 1/22/2016
• Welcome Address, Updates on Molecular Pathology and Morsani Molecular Laboratory 
  1/13/2016
• The Moffitt Cancer Center Biobank: An Integrated Approach to Support Personalized Medicine 
  San Diego, CA - 1/12/2016
• Moffitt Cancer Center Pathology 
  Cambridge, MA - 1/12/2016
• Anatomic Pathology's Quality Journey at Moffitt Cancer Center: Aligning Administration, Lab Leadership and Pathologists to Raise the Quality Bar 
  New Orleans, LA, 2015 - 1/12/2016
• Opportunities and challenges of using Digital Pathology in the CLIA laboratory 
  Chicago, IL - 1/11/2016
• TST15, TST170 and TruSight RNA and Myeloid Solutions and Scalability 
  Charlotte, NC - 1/9/2016
• Welcome Address, Transforming Discovery Into Practice 
  1/4/2016
• CLIA Multiplex Mutation Testing in Solid Tumors-Challenges & Opportunities – The Moffitt Experience 
  1/3/2016
• Multiplex IHC for Tumor Microenvironment 
  1/3/2016
• Current Concepts in Ovarian Cancer Pathogenesis & Updates from the Cancer Genome Atlas Ovarian Study 
  1/3/2016
• Update: Moffitt�s CLIA Molecular Lab New Capabilities and Applications 
  Moffitt Cancer Center, Tampa, FL - 1/1/2016
• New Technologies and Future Directions for the Assessment of Thyroid Nodules 
  Yokohama, Japan - 1/1/2016
• Our Experience with TST-15 
  Seattle, WA - 1/1/2016
• Tumor Markers in Breast and Ovarian Cancer 
  Moffitt Cancer Center, Tampa, FL - 1/1/2015
• Join now to see all

Other

• Ovarian Serous Cancer Study 
  Magliocco AM, Bay News 9, Moffitt Cancer Center
  1/1/2016
• Breast Cancer Diagnostics: Present and future in the AP lab. 
  Magliocco A
  Tampa, FL. - 1/16/2013
• Walk provides troops for cancer fight, funds used to buy cutting-edge technology. 
  Goldman S, Calgary Herald, Interview
  7/17/2007
• Cancer-fighting armour hits city. 
  McMurray J, Calgary Sun, Interview
  7/17/2007
• Fundraiser turns into a lifesaver. 
  McMurray J, Calgary Sun, Interview
  7/17/2007
• Researcher received funds from ACF in support of Weekend to End Breast Cancer. 
  Magliocco A, CTV Television Interview
  7/16/2007
• Pants dropped to raise awareness of cancer 
  Goldman S, Calgary Herald, Interview
  6/8/2007
• Walk provides troops for cancer fight, funds used to buy cutting-edge technology (Newspaper Article) 
  Calgary Herald
  1/17/2007
• Cancer-fighting armour hits city (Newspaper Article) 
  Calgary Sun
  1/17/2007
• Fundraiser turns into a lifesave (Newspaper Article) 
  Calgary Sun
  1/17/2007
• Researcher received funds from ACF in support of Weekend to End Breast Cancer 
  City TV
  1/16/2007
• Week-end to End Breast Cancer. 
  Magliocco A, Global Television Interview
  1/1/2007
• Week-end to End Breast Cancer 
  Global Television
  1/1/2007
• Positively Pink Celebrating Calgary Breast Cancer Breakthroughs. 
  Magliocco A, CTV, City TV Television Interview
  10/24/2006
• Role of Src Activation and Breast Cancer with funded support from Canadian Breast Cancer Foundation. 
  Magliocco A, Health Frontiers Interview, Radio Interview
  10/23/2006
• Weekend to End Breast Cancer informing the importance of the new ACF funding. 
  Magliocco A
  ACF 30 minute video filmed in Magliocco Translational Laboratories Tom Baker Cancer Centre, Calgary, - 5/26/2006
• Weekend to End Breast Cancer informing the importance of the new ACF funding (Video) 
  WEBC
  1/26/2006
• Positively Pink Celebrating Calgary Breast Cancer Breakthroughs 
  City TV
  1/24/2006
• Role of Src Activation and Breast Cancer with funded support from Canadian Breast Cancer Foundation (Raio Interview) 
  Health Frontiers
  1/23/2006
• Breast Cancer Research, CFCN, The Health Series. 
  Magliocco A
  Televison Intrerview - 1/1/2004
• Breast Cancer Research 
  CFCN, The Health Series
  1/1/2004
• Regulation of plasmin-dependent fibrin clot lysis by annexin II heterotetramer. 
  Choi KS, Fitzpatrick SL, Filipenko NR, Fogg DK, Kassam G, Magliocco AM, Waisman DM.
  7/1/2002
• Join now to see all